The results come from data that were amassed in two trials - ONTARGET and TRANSCEND - that were undertaken to see whether use of medications could reduce events such as heart attack, stroke, and heart failure in patients who were 55 years or older and who had established but stable cardiovascular disease or diabetes with end-organ damage.